The authors of a blog entry   in Health Affairs conclude:

“Coverage with Evidence Development (CED) is a promising solution to a continued problem in healthcare innovation: funding investigations of experimental services. As a result of the Wisdom study (Women Informed to Screen Depending On Measures of risk), Blue Shield has established new standardized policies and evaluation criteria and procedures for the use of CED to support studies that evaluate experimental services that have potential to improve healthcare value. This is a promising development that, through the experience of Wisdom and additional studies, will gain greater use with private payers to address a critical funding gap for comparative effectiveness studies.”

To read the study, please hit this link.